Literature DB >> 31468515

Therapeutics for dementia and Alzheimer's disease: New directions for precision medicine.

J A Duce1,2,3, X Zhu4, L H Jacobson2,5, P M Beart2,5.   

Abstract

LINKED ARTICLES: This article is part of a themed section on Therapeutics for Dementia and Alzheimer's Disease: New Directions for Precision Medicine. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.18/issuetoc.
© 2019 The British Pharmacological Society.

Entities:  

Year:  2019        PMID： 31468515      PMCID： PMC6715617          DOI： 10.1111/bph.14767

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  13 in total

Review 1.  Therapeutic Potential of α7 Nicotinic Acetylcholine Receptors.

Authors:  Daniel Bertrand; Chih-Hung L Lee; Dorothy Flood; Fabrice Marger; Diana Donnelly-Roberts
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 2.  The Cellular Phase of Alzheimer's Disease.

Authors:  Bart De Strooper; Eric Karran
Journal:  Cell       Date:  2016-02-11       Impact factor: 41.582

Review 3.  Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues.

Authors:  Lars M Ittner; Matthias Klugmann; Yazi D Ke
Journal:  Br J Pharmacol       Date:  2019-04-23       Impact factor: 8.739

Review 4.  Drug interactions with dementia-related pathophysiological pathways worsen or prevent dementia.

Authors:  Romain Barus; Johana Béné; Julie Deguil; Sophie Gautier; Régis Bordet
Journal:  Br J Pharmacol       Date:  2019-03-31       Impact factor: 8.739

Review 5.  Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.

Authors:  Natalia N Nalivaeva; Anthony J Turner
Journal:  Br J Pharmacol       Date:  2019-03-11       Impact factor: 8.739

6.  Neutralization of IL-17 rescues amyloid-β-induced neuroinflammation and memory impairment.

Authors:  Claudia Cristiano; Floriana Volpicelli; Pellegrino Lippiello; Benedetta Buono; Federica Raucci; Marialuisa Piccolo; Asif Jilani Iqbal; Carlo Irace; Maria Concetta Miniaci; Carla Perrone Capano; Antonio Calignano; Nicola Mascolo; Francesco Maione
Journal:  Br J Pharmacol       Date:  2019-03-03       Impact factor: 8.739

Review 7.  Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets.

Authors:  Francis J Herman; Sherry Simkovic; Giulio M Pasinetti
Journal:  Br J Pharmacol       Date:  2019-03-21       Impact factor: 8.739

Review 8.  Therapeutic targeting of nuclear receptors, liver X and retinoid X receptors, for Alzheimer's disease.

Authors:  Nicholas F Fitz; Kyong Nyon Nam; Radosveta Koldamova; Iliya Lefterov
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

Review 9.  The β-secretase (BACE) inhibitor NB-360 in preclinical models: From amyloid-β reduction to downstream disease-relevant effects.

Authors:  Ulf Neumann; Rainer Machauer; Derya R Shimshek
Journal:  Br J Pharmacol       Date:  2019-03-10       Impact factor: 8.739

Review 10.  The proteostasis network provides targets for neurodegeneration.

Authors:  Timothy Mark Newton; James Alex Duce; Elliott David Bayle
Journal:  Br J Pharmacol       Date:  2019-05-23       Impact factor: 8.739
View more
  2 in total

Review 1.  Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer's disease.

Authors:  Weiwei Yu; Haiqiang Jin; Yining Huang
Journal:  Clin Sci (Lond)       Date:  2021-01-15       Impact factor: 6.124

Review 2.  The Role of Obesity and Diabetes in Dementia.

Authors:  Ashley Selman; Scott Burns; Arubala P Reddy; John Culberson; P Hemachandra Reddy
Journal:  Int J Mol Sci       Date:  2022-08-17       Impact factor: 6.208
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.